Cardiac Resynchronization Algorithm for Therapy EvaluationUtilizing patent pending electrical biomarkers and computational modeling, CReATE provides patient-specific electro-anatomical heart models to aid physicians with the diagnosis of ventricular dyssynchrony, program cardiac resynchronization therapy devices and predict patient outcomes to cardiac resynchronization therapy. Initial clinical studies have shown a 30% increase in diagnostic accuracy as compared to current diagnostic methods. This increase in accuracy is due to the use of the patients cardiac imaging and electrical data as opposed to comparing current metrics to population level medical criteria. CReATE is the first mover within personalized cardiac electrophysiology diagnosis and is one of many companies developing personalized medicine solutions.